AZTANasdaqSpecial Industry Machinery, NECFiscal year ends September 30
Azenta, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$34.84+0.75 (+2.20%)
Close on Oct 19, 2026
- Market cap
- $1.58B
- P/E (TTM)
- –
- Dividend yield
- –
Azenta, Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Management Solutions | $324.59M | $318.90M | $303.19M | $304.56M | – | – | – | – | – | – | 54.7% | +1.8% |
| Multiomics | $269.23M | $254.55M | $248.30M | $250.94M | – | – | – | – | – | – | 45.3% | +5.8% |
| Core Products | $197.63M | $196.50M | $192.06M | $199.23M | – | – | – | – | – | – | 33.3% | +0.6% |
| Sample Repository Services | $126.96M | $122.39M | $111.13M | $105.33M | – | – | – | – | – | – | 21.4% | +3.7% |
| Operating Segments [Member] | – | – | – | – | – | – | – | – | – | $560.32M | – | – |
| Brooks Life Science Systems | – | – | – | – | – | – | – | – | $148.71M | $108.11M | – | – |
| Brooks Semiconductor Solutions Group | – | – | – | – | – | $508.74M | $446.67M | $435.02M | $378.79M | $325.90M | – | – |
| Brooks Life Sciences | – | – | – | – | – | – | $334.18M | $196.54M | $148.71M | $108.11M | – | – |
| Brooks Life Sciences Products | – | – | – | – | – | $129.76M | $119.02M | $106.15M | – | – | – | – |
| Brooks Life Sciences Services | – | – | – | – | – | $258.78M | $215.16M | $90.40M | – | – | – | – |
| Life Sciences Products | – | – | $305.18M | $199.23M | $199.61M | $129.76M | $119.02M | – | – | – | – | – |
| Life Sciences Services | – | – | $359.89M | $356.27M | $314.10M | $258.78M | $215.16M | – | – | – | – | – |
| B Medical Systems S.a.r.l. [Member] | – | $83.13M | $113.12M | $0 | – | – | – | – | – | – | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Management Solutions | $27.55M | $11.11M | -$2.29M | $23.97M | – | – | – | – | – | – | +148.1% |
| Multiomics | -$11.94M | -$7.73M | -$13.34M | $5.03M | – | – | – | – | – | – | +54.4% |
| Operating Segments [Member] | – | – | – | – | – | – | – | – | – | $31.48M | – |
| Brooks Life Science Systems | – | – | – | – | – | – | – | – | $4.70M | -$6.45M | – |
| Brooks Semiconductor Solutions Group | – | – | – | – | – | $82.95M | $69.96M | $62.51M | $42.74M | $16.63M | – |
| Brooks Life Sciences | – | – | – | – | – | – | $20.63M | $3.80M | $3.22M | -$6.45M | – |
| Brooks Life Sciences Products | – | – | – | – | – | $9.35M | -$1.84M | -$9.04M | – | – | – |
| Brooks Life Sciences Services | – | – | – | – | – | $28.83M | $22.47M | $12.84M | – | – | – |
| Life Sciences Products | – | – | -$30.32M | $11.03M | $23.09M | -$3.04M | -$20.88M | – | – | – | – |
| Life Sciences Services | – | – | -$14.72M | $10.78M | $22.66M | $2.86M | $8.98M | – | – | – | – |
| B Medical Systems S.a.r.l. [Member] | – | -$5.67M | $919.00K | $0 | – | – | – | – | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Services | $420.63M | $399.73M | $375.39M | $374.55M | $332.67M | $277.97M | $233.74M | $149.17M | $120.51M | – | 70.8% | +5.2% |
| Products | $173.19M | $173.72M | $176.10M | $180.95M | $181.04M | $110.57M | $100.44M | $482.39M | $406.99M | – | 29.2% | -0.3% |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $365.00M | $365.05M | $351.41M | $358.21M | $320.80M | $253.50M | $224.50M | $232.70M | $172.90M | $156.90M | 61.5% | -0.0% |
| Rest of Europe | $107.37M | $95.15M | $87.19M | $79.01M | $77.27M | $74.16M | $59.98M | $135.61M | – | – | 18.1% | +12.8% |
| China | $58.35M | $58.24M | $52.13M | $53.87M | $45.74M | $34.02M | – | – | – | – | 9.8% | +0.2% |
| United Kingdom | $35.39M | $27.20M | $26.66M | $30.26M | $31.54M | – | $48.76M | $51.69M | $37.28M | $31.34M | 6.0% | +30.1% |
| Asia Pacific [Member] | $23.28M | $21.32M | $25.63M | $32.83M | – | – | – | $262.71M | $255.83M | $196.12M | 3.9% | +9.2% |
| Other | $4.43M | $6.47M | $8.47M | – | – | – | – | – | – | – | 0.7% | -31.5% |
| North America | – | – | $359.42M | $361.11M | $323.98M | $256.17M | $226.40M | $233.24M | $174.43M | $157.43M | – | – |
| Rest of Europe | – | – | – | – | – | – | $92.60M | $83.92M | $59.96M | $49.13M | – | – |
| Asia Pacific and Other [Member] | – | – | – | – | $80.92M | $58.21M | $47.80M | $262.71M | $255.83M | – | – | – |
| Asia / Pacific / Other | – | – | $52.16M | $29.93M | $34.49M | $24.19M | – | – | – | – | – | – |
| Africa [Member] | – | $61.96M | $65.09M | $1.33M | $688.00K | – | – | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Azenta's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.